Teva Pharmaceuticals
TEVA
TEVA
455 hedge funds and large institutions have $3.76B invested in Teva Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 140 increasing their positions, 130 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1.04% less ownership
Funds ownership: 46.66% → 45.62% (-1%)
22% less capital invested
Capital invested by funds: $4.81B → $3.76B (-$1.05B)
Holders
455
Holding in Top 10
6
Calls
$361M
Puts
$334M
Top Buyers
| 1 | +$67.8M | |
| 2 | +$47.3M | |
| 3 | +$33.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$18.3M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$17.8M |
Top Sellers
| 1 | -$340M | |
| 2 | -$20.2M | |
| 3 | -$18.4M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$15.2M |
| 5 |
Millennium Management
New York
|
-$11.7M |